Pharmaceutical Fluid Handling Market Size, Share & Trends Analysis Report By Offering (Equipment & Solutions, Services), By Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, Silicone), By Application, By Usage, By End User, By Region, And by Segment Forecasts, 2023-2031
The Pharmaceutical Fluid Handling Market Size is valued at USD 10.28 Bn in 2022 and is predicted to reach USD 15.31 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031.
Pharmaceutical fluid handling is essential for delivering fluid medications such as cough syrups, intravenous medicines, and complicated active pharmaceutical components. Any firm that wants to flourish and be relied upon must invest in properly handling instruments and equipment. Automation cuts down on human mistakes, decreasing the number of lost samples.
The fluid handling equipment and production unit can be cleaned directly by automated handling without additional preparation. The application of AI for automated liquid handling provides promising prospects for the development of the market, such as the control of different phases of autonomous liquid handling and the use of internet connectivity to engage remotely with handlers.
In addition, key players' increased focus on new product development and strategic collaborations led to the growth of the global pharmaceutical fluid handling market. Companies in the pharmaceutical fluid handling market can anticipate substantial development prospects and increased spending on cutting-edge technology. It drives expansion globally and is expected to boost market expansion in the coming years.
Competitive Landscape:
Some Major Key Players In The Pharmaceutical Fluid Handling Market:
- CIRCOR International Inc
- Parker Hannifin Corp
- Danaher Corp
- Spirax Sarco Engineering plc
- Merck KGaA
- Rochling SE & Co KG
- RAUMEDIC AG
- Tef Cap Industries Inc
- Fraser Ross Ltd
- Australian Fluid Handling Pty Ltd.
Market Segmentation:
The pharmaceutical fluid handling market is segmented based on offering, tubing, application, usage, and end-users. Based on offering, equipment & solutions and services. By tubing, the market is segmented into thermoplastic elastomers, polyvinyl chloride, and silicone. By application, the market is segmented into fluid handling & management, fluid preparation, integration & automation, buffer management, and others. By usage, the market is segmented into cough syrup, intravenous products, complex active pharmaceutical ingredients, and others. By end user, the market is segmented into biotechnology companies, pharmaceutical & medical companies, and others.
Based On The Tubing, The Thermoplastic Elastomers Companies Pharmaceutical Fluid Handling Segment Is Accounted As A Major Contributor To The Pharmaceutical Fluid Handling Market
The thermoplastic elastomers companies' pharmaceutical fluid handling category is expected to record a major global market share in 2022. It is attributed because thermoplastic elastomers are highly processable and can be used in any standard extrusion or injection moulding facility. They may be reused often without breaking the bank and produce fewer emissions. The pharmaceutical and biomedical industries manufacture thermoplastic elastomer tubing with a high purity level.
Biotechnology Companies Segment To Witness Growth At A Rapid Rate
The biotechnology companies segment is estimated to grow rapidly in the global pharmaceutical fluid handling market. Innovative biologics for treating chronic diseases are mostly the domain of the biotechnology industry. Since the beginning of this decade, the industry has expanded thanks to more funding for R&D and more approvals from government agencies to market new products, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The North American Pharmaceutical Fluid Handling Market Holds A Significant Revenue Share
The North American pharmaceutical fluid handling market is expected to record the maximum market share in revenue in the near future. It can be attributed to the developments in healthcare infrastructure, the big domestic pharmaceutical industry and production facilities. The government also spends much on creating special industrial zones where infrastructure may be built and products can be made at a discount.
In addition, the presence of key market competitors and improvements in pharmaceutical fluid handling technology fuel expansion in the region's industries. In addition, Asia Pacific is projected to grow rapidly in the global pharmaceutical fluid handling market because of increased pharmaceutical R&D spending, rising pharmaceutical output, a maturing pharmaceutical sector, and growing financial support from the business.
Pharmaceutical Fluid Handling Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 10.28 Bn |
| Revenue Forecast In 2031 | USD 15.31 Bn |
| Growth Rate CAGR | CAGR of 4.6% from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Offering, Tubing, Application, Usage, and End User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | CIRCOR International Inc, Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Industries Inc, Fraser Ross Ltd, and Australian Fluid Handling Pty Ltd. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Pharmaceutical Fluid Handling Market-
Pharmaceutical Fluid Handling Market By Offering -
- Equipment & Solutions
- Services
Pharmaceutical Fluid Handling Market By Tubing -
- Thermoplastic Elastomers
- Polyvinyl Chloride
- Silicone
Pharmaceutical Fluid Handling Market By Application -
- Fluid Handling & Management
- Single-use Systems and Multi-use Systems
- Bioprocessing Workstations
- Standard Storage Systems and Biocontainers
- Totes
- Others
- Fluid Preparation
- Integration & Automation
- Aseptic Processing
- Buffer Management
- Others
Pharmaceutical Fluid Handling Market By Usage -
- Cough Syrup
- Intravenous Product
- Complex Active Pharmaceutical Ingredients
- Vaccine
- Medications for cancer treatments
- Others
- Others
Pharmaceutical Fluid Handling Market By End User -
- Biotechnology Companies
- Pharmaceutical & Medical Companies
- Others
Pharmaceutical Fluid Handling Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
The Pharmaceutical Fluid Handling Market Size is valued at USD 10.28 Bn in 2022 and is predicted to reach USD 15.31 Bn by the year 2031.
The Pharmaceutical Fluid Handling Market is expected to grow at a 4.6% CAGR during the forecast period for 2023-2031.
CIRCOR International Inc, Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Indu
Offering, Tubing, Application, Usage, and End User are the key segments of the Pharmaceutical Fluid Handling Market.
North American region is leading the Pharmaceutical Fluid Handling Market.